Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

Tumour Marker Predicts Malignancy in Biliary-Tract Cancers: Presented at AASLD By Maria Bishop BOSTON, MA -- November 9, 2007 -- A tumour marker known as tumour M2-pyruvate kinase (Tu-M2-PK) has been found capable of discriminating between benign and malignant biliary-tract cancer, British researchers reported here at the 58th Annual Scientific Meeting of the American Association for the Study of Liver Disease (AASLD). This finding means there may be a role for the Tu-M2-PK marker in the non-invasive screening of patients at increased risk of biliary-tract cancer, such as those with primary sclerosing cholangitis (PSC), noted lead author James H. Brindley, MD, The Institute of Hepatology, Royal Free & University College London Medical School, London, United Kingdom. In this study, 75 patients were recruited from the hepatobiliary service at University College Hospital, London, United Kingdom. Three cohorts included patients with biliary-tract cancer (n = 41, mean age 68 years), patients with PSC (n = 11, mean age 59 years), and patients with benign non-PSC conditions (n = 23, mean age 50 years). A commercially available enzyme-linked immunosorbent assay (ELISA) kit was utilised to measure plasma Tu-M2-PK markers. The results demonstrated mean plasma M2-PK levels of 114.8 +- 160.9 U/mL in patients with biliary-tract cancer (P =.001), 71.7 ± 81.6 in patients with PSC (P =.031), and 34.3 +- 20.6 in patients with non-PSC benign disease (P =.031). A correlation also was demonstrated between Tu-M2-PK and clinicopathological characteristics such as bilirubin level, tumour size, and the serum tumour marker CA 19-9. High plasma Tu-M2-PK levels in combination with raised serum CA 19-9 were associated with poor patient survival in biliary-tract cancer, the researchers stated. A high plasma Tu-M2-PK level also may indicate an aggressive biliary-tract cancer. A reliable, non-invasive tumour marker will be extremely useful in diagnosing biliary-tract cancers at an earlier stage of the disease, Dr. Brindley noted. Biliary-tract cancers have low prognoses unless they are caught early. Biliary cancers occur in the liver, pancreas, gallbladder, and extrahepatic bile ducts. In patients with PSC, the bile ducts inside and outside the liver become inflamed and scarred, eventually blocking the ducts and causing a build-up of bile that damages liver cells. Technical support for this study was provided by ScheBo-Biotech UK, Ltd. [Presentation title: Tumour M2-Pyruvate Kinase has a Diagnostic and Prognostic Role in Biliary Tract Cancer. Abstract 380] E-mail this page to a friend or colleague! To print, use this version